Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23664987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MVA Post-Event: Administration Timing and Boost Study
Condition: Smallpox
Interventions: Drug: Placebo (subcutaneous);   Drug: Placebo (scarification);   Biological: Dryvax®;   Biological: IMVAMUNE®

Study has passed its completion date and status has not been verified in more than two years.